European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

European equities traded in the US as American depositary receipts were trending higher late Tuesday morning following Monday's sell-off, rising 0.7% to 1,374.04 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biotech firm Evaxion Biotech (EVAX) and pharmaceutical company Novo Nordisk (NVO), which rose 3.3% and 3.2% respectively. They were followed by semiconductor company Sequans Communications (SQNS) and biopharmaceutical company Genfit (GNFT), which increased 2.7% and 2.5% respectively.

The decliners from continental Europe were led by biopharmaceutical company Cellectis (CLLS) and financial services company Banco Bilbao Vizcaya Argentaria (BBVA), which fell 2.9% and 1.1% respectively. They were followed by accommodation booking company trivago (TRVG) and internet browser company Opera (OPRA), which dropped 0.5% and 0.2% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Amarin (AMRN) and cruise line operator Carnival (CUK), which increased 3.8% and 3.3% respectively. They were followed by biopharmaceutical company Verona Pharma (VRNA) and telecommunications operator Vodafone Group (VOD), which were up 2.6% and 1.9% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company TC Biopharm (TCBP) and biotech firm Autolus Therapeutics (AUTL), which lost 6.6% and 4.7% respectively. They were followed by pharmaceutical company GSK (GSK) and biopharmaceutical company Adaptimmune Therapeutics (ADAP), which were down 1.5% and 0.04% respectively.